» Articles » PMID: 12024990

Monoclonal Antibodies. A Review

Overview
Specialty General Medicine
Date 2002 May 25
PMID 12024990
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects.

Ercilla-Rodriguez P, Sanchez-Diez M, Alegria-Aravena N, Quiroz-Troncoso J, Gavira-ONeill C, Gonzalez-Martos R Front Immunol. 2024; 15:1333150.

PMID: 39091493 PMC: 11291200. DOI: 10.3389/fimmu.2024.1333150.


The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics.

Khatib S, Salla M Leuk Res Rep. 2022; 18:100335.

PMID: 35832747 PMC: 9272380. DOI: 10.1016/j.lrr.2022.100335.


Multi attribute method implementation using a High Resolution Mass Spectrometry platform: From sample preparation to batch analysis.

Carvalho S, Gomes R, Pfenninger A, Fischer M, Strotbek M, Isidro I PLoS One. 2022; 17(1):e0262711.

PMID: 35085302 PMC: 8794205. DOI: 10.1371/journal.pone.0262711.


Next-generation antibody-based therapies in neurology.

Ruck T, Nimmerjahn F, Wiendl H, Lunemann J Brain. 2021; 145(4):1229-1241.

PMID: 34928330 PMC: 9630709. DOI: 10.1093/brain/awab465.


Biological drug therapy for ocular angiogenesis: Anti-VEGF agents and novel strategies based on nanotechnology.

Formica M, Awde Alfonso H, Palma S Pharmacol Res Perspect. 2021; 9(2):e00723.

PMID: 33694304 PMC: 7947217. DOI: 10.1002/prp2.723.